Item 1.01 Entry into a Material Definitive Agreement.

On January 27, 2022, Advaxis, Inc., a Delaware corporation (the "Company"), entered into a Securities Purchase Agreement (the "Purchase Agreement") with several institutional investors, pursuant to which the Company agreed to issue and sell, in a private placement (the "Offering"), 1,000,000 shares of the Company's Series D Convertible Redeemable Preferred Stock, par value $0.001 per share (the "Series D Preferred Stock"), at an offering price of $4.75 per share, representing a 5% original issue discount ("OID") to the stated value of $5.00 per share, for gross proceeds of approximately $4.75 million in the aggregate for the Offering, before the deduction of the fees and offering expenses of the Company's financial advisor. The shares of Series D Preferred Stock will be convertible, at a conversion price of $0.25 per share (subject in certain circumstances to adjustments), into shares of the Company's common stock, par value $0.001 per share (the "Common Stock"). The Purchase Agreement contains customary representations, warranties and agreements by the Company and customary conditions to closing. The closing of the Offering is expected to occur on January 31, 2022.

The Company intends to call a special meeting of stockholders to consider an amendment (the "Amendment") to the Company's Amended and Restated Certificate of Incorporation (the "Charter"), to effect a reverse stock split of the outstanding shares of common stock ("Common Stock") by a ratio to be determined by the Board of Directors of the Company within a range to be specified in the proposal put to the stockholders for approval of the Amendment (the "Reverse Stock Split"). The Investors have agreed in the Purchase Agreement to not transfer, offer, sell, contract to sell, hypothecate, pledge or otherwise dispose of the shares of the Series D Preferred Stock until the Reverse Stock Split and to vote the shares of the Series D Preferred Stock purchased in the Offering in a manner that "mirrors" the proportions on which the shares of Common Stock (excluding any shares of Common Stock that are not voted) are voted on the Reverse Stock Split and the Amendment. The Amendment requires the approval of the majority of the votes associated with our outstanding stock entitled to vote on the proposal. Since the Series D Preferred Stock will mirror only votes cast, abstentions or broker non-votes by common stockholders, which would ordinarily have the effect of a no vote, will not have any effect on the outcome of the vote.

Pursuant to the Purchase Agreement, prior to the closing of the Offering, the Company will file a certificate of designation (the "Certificate of Designation") with the Secretary of the State of Delaware designating the rights, preferences and limitations of the shares of Series D Preferred Stock. The Certificate of Designation will provide, in particular, that the Series D Preferred Stock will have no voting rights, other than the right to vote as a class on certain specified matters, except that each share of Series D Preferred Stock will have the right to cast 30,000 votes per share of Series D Preferred Stock on the Reverse Stock Split.

The holders of Series D Preferred Stock will be entitled to dividends, on an as-if converted basis, equal to dividends actually paid, if any, on shares of Common Stock. The Series D Preferred Stock is convertible into shares of Common Stock at a rate of $0.25 per share for the Series D Preferred Stock. The conversion price can be adjusted pursuant to the Certificate of Designation for stock dividends and stock splits, subsequent rights offering, pro rata distributions of dividends or the occurrence of a fundamental transaction (as defined in the applicable Certificate of Designation). The Series D Preferred Stock can be converted at the option of the holder at any time after the Company has received stockholder approval for the Reverse Stock Split and filed the requisite Amendment with the Delaware Secretary of State's office to effectuate the Reverse Stock Split (the "Reverse Stock Split Date"), subject to beneficial ownership limitations set forth in the applicable Certificate of Designation. In addition, on or after the Reverse Stock Split Date, and subject to the satisfaction of certain conditions, the Company can cause the holder of the Series D Preferred Stock to convert their shares of Series D Preferred Stock, subject to such beneficial ownership limitations.

Each holder of the Series D Preferred Stock shall have the right to cause the Company to redeem all or part of their shares of the Series D Preferred Stock from the earlier of receipt of stockholder approval of the reverse stock split or 90 days following the original issue date until 120 days following the original issue date, the "Redemption Date," in cash at a redemption price equal to 105% of the stated value plus an amount equal to accumulated but unpaid dividends, if any, on such shares (whether or not earned or declared, but excluding interest on such dividends) up to, but excluding, the Redemption Date. Under certain circumstances, the commencement of the period during which the Series D Preferred Stock may be redeemed may be extended from 90 days following the original issue date to 135 days following the original issue date, in which case the Redemption Date would be extended to 165 days following the original issue date. Should such extension occur, the redemption price would be increased to an amount equal to 110% of the stated value plus an amount equal to accumulated but unpaid dividends, if any, on such shares.

The proceeds of the Offering will be held in an escrow account, along with an additional $500,000 to be deposited by the Company to cover the aggregate OID as . . .

Item 3.03. Material Modifications to Rights of Security Holders.

The disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference.

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The disclosure required by this Item and included in Item 1.01 of this Current Report is incorporated herein by reference.

Also on January 27, 2022, the Company filed a Certificate of Correction to the Amended and Restated Certificate of Incorporation and six separate Certificates of Correction to Certificates of Amendment of the Amended and Restated Certificate of Incorporation (collectively. the "Certificates of Correction") correcting the articles within the Amended and Restated Certificate of Incorporation to include inadvertently omitted language concerning the power of the Board of Directors of the Company to designate, authorize and issue "blank check" preferred stock.

Copies of the Certificates of Correction are attached hereto as Exhibits 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, and 3.7, and are incorporated by reference herein.

On January 27, 2022, the Board of Directors of the Company approved by unanimous written consent Amendment No. 2 to the Second Amended and Restated By-Laws (the "By-Laws Amendment"), which became effective immediately.

The Board of Directors amended Section 4 of Article I of the Second Amended and Restated By-Laws (the "By-Laws"), such that the By-Laws, as amended, provide that for the purpose of establishing a quorum at all meetings of the stockholders for the transaction of business, shares shall be counted as follows: (i) the numbers of shares of common stock that are issued and outstanding and (ii) the number of shares of preferred stock that are issued and outstanding (counting for these purposes (in respect of each share of preferred stock outstanding) the number of shares of common stock that are, or will be, issuable upon conversion of each such currently issued and outstanding share of preferred stock).

The Board of Directors also amended Section 5 of Article I of the By-Laws, such that in all matters other than the election of directors, the affirmative vote of the majority in voting power of shares present in person or represented by proxy at the meeting and entitled to vote is required.

The foregoing description of the By-Laws Amendment does not purport to be complete and is qualified entirely by reference to the full text of the By-Laws Amendment, which is attached as Exhibit 3.9 hereto and is incorporated by reference herein.




Item 8.01 Other Events

The Company issued a press release announcing the Offering on January 28, 2022. A copy of the press release is attached hereto as Exhibit 99.1, and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(a) Not Applicable.



(b) Not Applicable.



(c) Not Applicable.



(d) Exhibits



Exhibit
Number       Description
3.1            Certificate of Correction to the Amended and Restated Certificate
             of Incorporation of Advaxis, Inc., filed with the Secretary of State
             of the State of Delaware on January 27, 2022
3.2            Certificate of Correction to the Certificate of Amendment of the
             Amended and Restated Certificate of Incorporation of Advaxis, Inc.,
             filed with the Secretary of State of the State of Delaware on January
             27, 2022
3.3            Certificate of Correction to the Certificate of Amendment of the
             Amended and Restated Certificate of Incorporation of Advaxis, Inc.,
             filed with the Secretary of State of the State of Delaware on January
             27, 2022
3.4            Certificate of Correction to the Certificate of Amendment of the
             Amended and Restated Certificate of Incorporation of Advaxis, Inc.,
             filed with the Secretary of State of the State of Delaware on January
             27, 2022
3.5            Certificate of Correction to the Certificate of Amendment of the
             Amended and Restated Certificate of Incorporation of Advaxis, Inc.,
             filed with the Secretary of State of the State of Delaware on January
             27, 2022
3.6            Certificate of Correction to the Certificate of Amendment of the
             Amended and Restated Certificate of Incorporation of Advaxis, Inc.,
             filed with the Secretary of State of the State of Delaware on January
             27, 2022
3.7            Certificate of Correction to the Certificate of Amendment of the
             Amended and Restated Certificate of Incorporation of Advaxis, Inc.,
             filed with the Secretary of State of the State of Delaware on January
             27, 2022
3.8            Form of Certificate of Designation of Preferences, Rights and
             Limitations of Series D Convertible Redeemable Preferred Stock
3.9            Amendment No. 2 to the Second Amended and Restated By-Laws of
             Advaxis, Inc  .
10.1           Form of Securities Purchase Agreement between Advaxis, Inc. and the
             investors thereto, dated January 27, 2022
10.2           Form of Registration Rights Agreement by and among Advaxis, Inc.
             and the investors named therein
99.1           Press Release of Advaxis, Inc. dated January 28, 2022 announcing
             the pricing of the Offering
104          Cover Page Interactive Data File (embedded within the Inline XBRL
             document)

© Edgar Online, source Glimpses